Products

Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together.  

Below you can find the full A-Z list of our products available in the United States.

 

All product areas
Filter by product area

Filter by product area

Trademark Generic Product area
Advair Diskus salmeterol, fluticasone propionate General medicines
Advair HFA salmeterol, fluticasone propionate General medicines
Anoro Ellipta umeclidinium and vilanterol General medicines
Arexvy respiratory syncytial virus vaccine, adjuvanted Vaccines
Arnuity Ellipta fluticasone furoate inhalation powder General medicines
Beconase beclomethasone dipropionate General medicines
Benlysta belimumab Specialty medicines
Bexsero meningitis B Vaccines
Boostrix tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed Vaccines
Breo Ellipta fluticasone furoate, vilanterol General medicines
Engerix-B hepatitis B Vaccine (Recombinant) Vaccines
Epivir HBV lamivudine Specialty medicines
Flolan epoprostenol General medicines
Flovent Diskus fluticasone propionate General medicines
Flovent HFA fluticasone propionate General medicines
Fluarix (trivalent) & Fluarix (quadrivalent) seasonal influenza vaccine (3 strain and 4 strain) Vaccines
FluLaval (trivalent) & FluLaval (quadrivalent) seasonal influenza vaccine (3 strain and 4 strain) Vaccines
Havrix hepatitis A vaccine, inactivated Vaccines
Hiberix haemophilus B conjugate vaccine (tetanus toxoid conjugate) Vaccines
Imitrex Injection sumatriptan succinate General medicines
Imitrex Nasal Spray sumatriptan succinate General medicines
Imitrex Tablets sumatriptan succinate General medicines
Incruse Ellipta umeclidinium inhalation powder General medicines
Infanrix diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed Vaccines
Jemperli dostarlimab Specialty medicines
Kinrix diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine Vaccines
Krintafel tafenoquine General medicines
Lamictal / Lamictal ODT lamotrigine General medicines
Lamictal XR lamotrigine General medicines
Malarone atovaquone and proguanil hydrochloride General medicines
Menveo meningitis ACWY Vaccines
Mepron atovaquone General medicines
Nucala mepolizumab Specialty medicines
Ojjaara momelotinib Specialty medicines
Pediarix diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Vaccines
Priorix measles, mumps, and rubella vaccines, live Vaccines
Relenza zanamivir General medicines
Rotarix human rotavirus vaccine, live attenuated Vaccines
Rythmol SR propafenone HCL General medicines
Serevent Diskus salmeterol xinafoate General medicines
Shingrix zoster vaccine recombinant, adjuvanted Vaccines
Soriatane acitretin General medicines
Trelegy Ellipta fluticasone furoate, umeclidinium, and vilanterol inhalation powder General medicines
Twinrix combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen) Vaccines
Valtrex valaciclovir hydrochloride General medicines
Ventolin HFA albuterol General medicines
Wellbutrin SR bupropion hydrochloride General medicines
Zejula niraparib Specialty medicines

Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations.

If you are a healthcare professional, you can access more product information on our GSKPro website.

In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center

Our therapeutic areas

Shingles Science Image

Vaccines

Vaccines

Our broad vaccines portfolio targets infectious diseases at every stage of life, helping to protect people frommeningitis, shingles, RSV, flu, polio and many more.Our portfolio of more than 20 marketed vaccines is one ofthe industry’s broadest. We deliver over 1.5 million doses ofour vaccines every day; and 4 out of 10 infants born eachyear receive at least one GSK vaccine. Our vaccinesportfolio targets infectious diseases at every stage of life,helping to protect people from RSV, meningitis, shingles, flu,polio and many more.

HIV Science Image

Specialty medicines

Specialty medicines

Specialty medicines are prescribed by specialist healthcare practitioners.

Our portfolio of specialty medicines prevents and treats diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Many are first or best-in-class. Our specialty medicines is focused on four therapeutic areas: infectious diseases, HIV, respiratory/immunology and oncology. We’re leaders in infectious diseases and HIV innovation and we’re building our positions in immunology and oncology. 

Escherichia Coli (E. Coli) Bacteria Science Image

General medicines

General medicines

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners.

General medicines include our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases, in a portfolio which includes pre-launch R&D assets, growth and established products.  Every day, our general medicines improve health and make life better for millions all over the world and our portfolio of more than 150 primary care products supplied in 112 countries worldwide.

Influenza Science Image

Infectious diseases

Infectious diseases

There’s a huge need for innovation to tackle chronic infections, seasonal infections, common childhood diseases, rare but devastating conditions (meningitis) and a range of bacterial infections made more challenging by antimicrobial resistance (AMR); as well as diseases which predominately impact lower-income countries like malaria and TB.

Our infectious diseases portfolio is the broadest in the industry and, including HIV, accounts for two thirds of our pipeline.

HIV Science Image

HIV

HIV

Our goal is to minimise the impact of HIV on people’s lives through treatment, prevention and ultimately cure.

We are a world leader in next-generation HIV treatment and prevention, through ViiV Healthcare, the world’s only specialist HIV pharmaceutical company, which we majority own. We pioneered the first HIV treatments in the 1980s and we are leading the way in changing the landscape for people living with HIV today.

Lupus Science Image

Respiratory/Immunology

Respiratory/Immunology

We’re unlocking the science of the immune system to develop medicines for immune-mediated conditions including lupus, eosinophilic-driven diseases such as severe eosinophilic asthma, COPD and other inflammatory diseases. 

Our innovative medicines help millions of people with immune and respiratory conditions.

Immuno Oncology Science Image

Oncology

Oncology

Our approach in oncology is to prioritise the development of novel medicines to treat blood and women’s cancers and to explore other potential breakthroughs in immuno-oncology.  

We have 11 investigational medicines in our oncology pipeline that have the potential to make a meaningful difference for patients with cancer, and we’re growing our pipeline through targeted business development.